AKT |
Protein kinase-B |
Bcl-2 |
B cell lymphoma-2 |
BH3 |
Bcl-2 homology 3 |
BrdU |
Bromodeoxyuridine |
CA125 |
Cancer antigen 125 |
CBD |
Collagen-binding domains |
CCK-8 |
Cell counting kit 8 |
CRD |
Carbohydrate recognition domain |
CTLA-4 |
Cytotoxic T-lymphocyte associated factor-4 |
Cyt C |
Cytochrome C |
DBF |
Dibenzofuran |
DDR |
DNA damage response |
DFS |
Disease free survival |
EGFR |
Epidermal growth factor receptor |
EMT |
Epithelial mesenchymal transition |
ELISA |
Enzyme-linked immunosorbent assay |
FITC |
Fluorescein isothiocyanate |
Gal-1 |
Galectin-1 |
Gal-11 |
Galectin-11 |
Gal-13 |
Galectin-13 |
Gal-14 |
Galectin-14 |
Gal-15 |
Galectin-15 |
Gal-2 |
Galectin-2 |
Gal-3 |
Galectin-3 |
Gal-5 |
Galectin-5 |
Gal-7 |
Galectin-7 |
Gal-8 |
Galectin-8 |
Gal-9 |
Galectin-9 |
HIV |
Human immunodeficiency virus |
HGSC |
High grade serous cancer |
IL-17 |
Interleukin-17 |
Il-2 |
Interleukin-2 |
JNK1 |
C-jun-NH2-terminal kinase 1 |
LPS |
Lipopolysaccharide |
MALP2 |
Macrophage-activating lipopetide-2 |
MET |
Mesenchymal epithelial transition |
MTT |
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
MUC1 |
Mucin 1 |
MUC5AC |
Mucin 5AC |
MUC6 |
Mucin 6 |
MUC16 |
Mucin 16 |
NF-IL6 |
Nuclear factor for interleukin 6 |
NWGR |
Aspartate-tryptophan-glycine-arginine |
OS |
Overall survival |
PBMC |
Peripheral blood mononuclear cell |
PFS |
Progression free survival |
PI3K |
Phosphoinositol 3 kinase |
shRNA |
Small hairpin RNA |
siRNA |
Small interfering RNA |
TG |
Thomsen–Friedenreich (TF) |
TLR |
Toll-like receptor |
TLR-3 |
Toll-like receptor-3 |
TLR-4 |
Toll-like receptor-4 |
TMA |
Tissue microarray |
Treg |
T regulatory |